Where does Minerva Surgical, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Minerva Surgical, Inc. ranks #5,172 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Minerva Surgical, Inc. hold?

Minerva Surgical, Inc. holds 67 US utility patents granted between 2015 and 2025, spanning 3 technology areas.

What is Minerva Surgical, Inc.'s Innovation Score?

Minerva Surgical, Inc. has an Innovation Score of 44.8 out of 100 (top 25% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Minerva Surgical, Inc. focus on?

Minerva Surgical, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 67 patents, ranking #274 of 7,127 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

Is Minerva Surgical, Inc.'s patent grant rate increasing or decreasing?

Minerva Surgical, Inc.'s recent grant velocity is +52% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Minerva Surgical, Inc.'s patents?

Minerva Surgical, Inc.'s patents average 17.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Minerva Surgical, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Minerva Surgical, Inc.

USPTO PatentsView assignee record - 67 granted patents across 3 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Minerva ranks #5,172 of 49,997 tracked US assignees by granted-patent volume, with 67 patents across 3 technology areas.

#5,172
of 49,997 US assignees by volume: Top 25%
by Innovation Score (44.8/100): 17.1
avg claims per patent: +52%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5172 · US Corporation #5,172 · 67 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 67 grants
UPPER-Q #5,172/49,997
PHOTO-FINISH Lodestar Licensing…
CPC-NARROW A61B · 3 areas
INNOV-PAR 44.8/100
CLAIMS-RICH 17.1 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +52% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Lodestar Licensing Group LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Minerva’s 44.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 14.6 pts (33%) Velocity 13.9 pts (31%) Breadth 6.1 pts (14%) Claim depth 10.2 pts (23%)

Qualcomm Incorporated · highest

85
Adata Technology · near

45
Experian Information… · near

45
Flytech Technology · near

45
Minerva Surgical · this assignee

45
SI-Bone · near

45
3D Lighting… · lowest

7

What this shows Minerva's Innovation Score is 44.8/100 (top 25% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Minerva?

Each dot is one of Minerva’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Minerva’s own 17.1 claims/patent is ABOVE the 16.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Minerva vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Minerva's grants concentrate

Minerva Surgical, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2024 (11 grants) versus a trough of 2 in 2019. By volume, Minerva sits between Lumileds Holding B.V. and National University of Ireland, Galway.

Minerva's three-year grant acceleration

Minerva Surgical, Inc. shows 25 grants in 2022–2024 against only 12 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Lumileds Holding…

67
Lodestar Licensin…

67
Lumentum Japan

67
Mabuchi Motor

67
Magna Powertrain

67
Moen Incorporated

67
NCS Multistage

67
National Universi…

67
Minerva Surgical ◀

67

What this shows Minerva holds 67 patents at rank #5,171, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Minerva

By rank, the assignees closest to #5,171 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Minerva's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Minerva, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Minerva ranks #274 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (45 here).

SI-Bone Inc. 45 Experian Information Solutions, Inc. 45 Flytech Technology Co., Ltd. 45 Adata Technology Co., Ltd. 45

Similar claim depth

Nearest assignees by average claims per patent (17.1 here).

UNL Holdings LLC 17.1 avg Integrity Implants Inc. 17.1 avg The Board of Trustees of The University of Alabama 17.1 avg Valeo Vision 17.1 avg

Minerva's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 25% higher than 75% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Minerva Surgical, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	6	9.0%
2016	4	6.0%
2017	7	10.4%
2018	4	6.0%
2019	2	3.0%
2020	5	7.5%
2021	5	7.5%
2022	7	10.4%
2023	7	10.4%
2024	11	16.4%
2025partial year	9	13.4%

Which technologies does Minerva Surgical, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 67

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 10

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 2

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Minerva Surgical, Inc.'s patent record in context - here's where to go next.

Minerva Surgical, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #5,172 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Minerva Surgical, Inc. against Lumileds Holding B.V., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 44.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.